mdlinx mdlinx

Rheumatology - Autoimmune/Heritable News & Articles

What you'll find here at MDLinx Rheumatology: The top rheumatology clinical articles of the day, plus MDLinx exclusive content

  • Our medical editors bring you the best key learnings published in the top peer-reviewed rheumatology medical journals. You'll find overviews here ranked and organized by topic on rheumatoid arthritis, joint and back pain, osteoarthritis, lupus and autoimmune diseases, osteoporosis and bone fractures. In a matter of minutes, you and all the members of your patient care team can stay current on the literature as it is published.
  • MDLinx exclusive content includes monthly highlights from our physician editor, D. Scott Cunningham, MD, PhD, as well as clinical pearls from The Smartest Internist, The Smartest Family Physician, and The Smartest Pediatrician daily quiz challenges.

Your Unread Messages in Rheumatology

See All >> Messages include industry-sponsored communications and special communications from MDLinx

Articles

Latest (3) Full Text Articles (22) Focus on Fibromyalgia
Ranked, sorted, and summarized by MDLinx editors from the latest literature
Topics:

261 Type I interferons in Sjogrens syndrome Autoimmunity Reviews, March 14, 2013    Review Article

262 [18F]FDG uptake in proximal muscles assessed by PET/CT reflects both global and local muscular inflammation and provides useful information in the management of patients with polymyositis/dermatomyositis Rheumatology, March 14, 2013    Clinical Article

263 Perspectives on epigenetic based immune intervention for rheumatic diseases Arthritis Research & Therapy, March 14, 2013    Clinical Article

264 A comparison of clinician-rated neuropsychological and self-rated cognitive assessments in patients with asthma and rheumatologic disorders Allergy and Asthma Proceedings, March 14, 2013    Review Article

265 Laryngeal involvement in Behcets disease--a challenge for treatment Clinical Rheumatology, March 14, 2013

266 Successful treatment of osteomalacia caused by renal tubular acidosis associated with Sjogrens syndrome Modern Rheumatology, March 14, 2013    Clinical Article

267 Discoid Lupus Alopecia Complicated by Frontal Fibrosing Alopecia on a Background of AGA British Journal of Dermatology, March 14, 2013    Review Article

268 A case of adult-onset Stills disease complicated by thrombotic thrombocytopenic purpura with retinal microangiopathy and rapidly fatal cerebral edema Modern Rheumatology, March 14, 2013

269 Ganghwaljetongyeum, an anti-arthritic remedy, attenuates synoviocyte proliferation and reduces the production of proinflammatory mediators in macrophages: The therapeutic effect of GHJTY on rheumatoid arthritis Full Text BMC Complementary and Alternative Medicine, March 13, 2013    Clinical Article

270 Successful plasma exchange combined with rituximab therapy in aggressive APS-related cutaneous necrosis Clinical Rheumatology, March 13, 2013

271 Association of interleukin-1 receptor-associated kinase (IRAK1) gene polymorphisms (rs3027898, rs1059702) with systemic lupus erythematosus in a Chinese Han population Inflammation Research, March 13, 2013    Review Article

272 Confirmation of TNIP1 but not RHOB and PSORS1C1 as systemic sclerosis risk factors in a large independent replication study Annals of Rheumatic Diseases, March 12, 2013    Clinical Article

273 Autoantibodies to citrullinated fibrinogen compared with anti-MCV and anti-CCP2 antibodies in diagnosing rheumatoid arthritis at an early stage: data from the French ESPOIR cohort Annals of Rheumatic Diseases, March 12, 2013    Clinical Article

274 Cryptococcosis of lumbar vertebra in a patient with rheumatoid arthritis and scleroderma: case report and literature review Full Text BMC Infectious Diseases, March 12, 2013    Review Article

275 Genome-wide association study identifies GIMAP as a novel susceptibility locus for Behcets disease Annals of Rheumatic Diseases, March 11, 2013    Clinical Article

276 Back to the future: oral targeted therapy for RA and other autoimmune diseases Nature Reviews Rheumatology , March 11, 2013    Clinical Article

277 The schedule of administration of canakinumab in cryopyrin associated periodic syndrome is driven by the phenotype severity rather than the age Arthritis Research & Therapy, March 11, 2013    Clinical Article

278 Patients with non-Jo-1 anti-tRNA-synthetase autoantibodies have worse survival than Jo-1 positive patients Annals of Rheumatic Diseases, March 11, 2013    Review Article

279 New insight on the Xq28 association with systemic sclerosis Annals of Rheumatic Diseases, March 8, 2013    Clinical Article

280 Gastric Antral Vascular Ectasia and Its Clinical Correlates in Patients with Early Diffuse Systemic Sclerosis in the SCOT Trial The Journal of Rheumatology, March 8, 2013    Clinical Article

50 available pages First Previous 14 15 16 17 18 19 20 21 22 23 Next Last

Clinical Pearls in Rheumatology

Highlights in Rheumatology

ACPA correlate with disease progression in JIA

In a study involving 74 patients with juvenile idiopathic arthritis (JIA), 26 patients had detectable anti-citrullinated protein antibodies (ACPA). The ACPA titers correlated with disease progression at baseline and after a median follow-up of 11.5 months. In addition to predicting disease severity and progression, the authors concluded that ACPA were superior to IgM-RF in diagnosing JIA.

Read the article summary

Predicting cardiovascular mortality in SLE

In a study involving 208 patients with SLE followed for 12 years, 42 deaths occurred, 48% of which were considered to be cardiovascular mortalities. Age, increased cystatin C levels, and arterial disease were predictive of all-cause mortality. Cigarette smoking and increased sVCAM-1, hsCRP, abeta2GP1, and aPL antibody levels were predictive of cardiovascular mortality.

Read the article summary

Anti-apoA-1 antibodies predict cardiovascular disease in RA patients

In a study conducted at the University of Geneva involving 118 patients with rheumatoid arthritis, but without cardiovascular disease at baseline, the 10-year Framingham cardiovascular risk score (FRS) was improved with the inclusion of the anti-apoA-1 antibody titer. The median follow-up was 9 years and the incidence of cardiovascular disease was 16%. Other biomarkers, including the NT-proBNP, oxLDL, CRP, and RF levels and the anti-citrullinated peptide antibody titer, did not improve the FRS.

Read the article summary

Get reports via email to claim your reading activity at MDLinx as Category 2 CME (It takes less than a minute)

Most Popular Rheumatology Articles

Last month's top read Top Articles of 2012

Indexed Journals in Rheumatology: Arthritis & Rheumatism, Annals of Rheumatic Diseases, Journal of Rheumatologymore

Other Topics in Rheumatology

Register now to view all the MDLinx contents (FREE)!

  • Stay current on the latest literature, research and clinical news
  • Get special communications and offers from MDLinx and our sponsors
  • Receive invitations to paid market research
View Samples and Register

Stay current - Media Tool

Newsletter
RSS
Follow Us
Facebook

Receive free subspecialty
"5-minute updates" via email

Sign up!

Send the E-mail Newsletter to a Colleague


Send

Subscribe to our free RSS feeds:
Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More

Follow Us on Twitter
Twitter is a rich source of instantly updated information. Join today and follow @MDLinx to start receiving tweets. Learn More

Close